ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
14.27
+0.45 (3.26%)
Nov 18, 2026, 12:11 PM EST - Market open
ADARx Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, ADARx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $34.25. The average 1-year stock price forecast is 140.01% higher than the current stock price, while the lowest is $32 (+124.25%) and the highest is $38 (+166.29%).
Price Target: $34.25 (+140.01%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ADARx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $32 | Buy | Maintains | $32 | +124.25% | Nov 13, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +166.29% | Oct 20, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 20, 2026 |
| UBS | UBS | Buy Initiates $35 | Buy | Initiates | $35 | +145.27% | Oct 20, 2026 |
Financial Forecast
Revenue This Year
6.21M
from 3.45M
Increased by 80.10%
Revenue Next Year
39.87M
from 6.21M
Increased by 541.88%
EPS This Year
-2.03
EPS Next Year
-1.45
from -2.03
EPS and Forward PE are based on non-GAAP adjusted numbers.